IE
RLAY icon

Israel Englander’s Relay Therapeutics RLAY Stock Holding History

Israel Englander’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
591,675
+243,942
+70% +$3.54M ﹤0.01% 2185
2026
Q1 		$3.46M Sell
347,733
-549,176
-61% -$4.91M ﹤0.01% 3337
2025
Q4 		$7.59M Buy
896,909
+152,865
+21% +$1.09M ﹤0.01% 2560
2025
Q3 		$3.88M Sell
744,044
-1,126,318
-60% -$4.29M ﹤0.01% 3400
2025
Q2 		$6.47M Sell
1,870,362
-1,072,513
-36% -$3.19M ﹤0.01% 2717
2025
Q1 		$7.71M Buy
2,942,875
+374,491
+15% +$1.47M ﹤0.01% 2444
2024
Q4 		$10.6M Buy
2,568,384
+1,508,777
+142% +$8.21M 0.01% 2121
2024
Q3 		$7.5M Sell
1,059,607
-89,570
-8% -$669K ﹤0.01% 2467
2024
Q2 		$7.49M Buy
1,149,177
+921,271
+404% +$6.29M ﹤0.01% 2342
2024
Q1 		$1.89M Buy
227,906
+40,940
+22% +$399K ﹤0.01% 3788
2023
Q4 		$2.06M Sell
186,966
-771,232
-80% -$6.51M ﹤0.01% 3579
2023
Q3 		$8.06M Sell
958,198
-615,959
-39% -$6.62M ﹤0.01% 2259
2023
Q2 		$19.8M Buy
+1,574,157
New +$19.6M 0.01% 1403
2023
Q1 		– Sell
-575,136
Closed -$10.3M – 6776
2022
Q4 		$8.59M Buy
575,136
+534,902
+1,329% +$10.2M ﹤0.01% 2298
2022
Q3 		$900K Sell
40,234
-145,323
-78% -$3.19M ﹤0.01% 4426
2022
Q2 		$3.11M Buy
185,557
+171,797
+1,249% +$3.68M ﹤0.01% 3261
2022
Q1 		$412K Sell
13,760
-7,273
-35% -$176K ﹤0.01% 5269
2021
Q4 		$646K Buy
21,033
+3,275
+18% +$103K ﹤0.01% 4816
2021
Q3 		$560K Buy
+17,758
New +$598K ﹤0.01% 5243
2021
Q2 		– Sell
-22,958
Closed -$794K – 7016
2021
Q1 		$794K Sell
22,958
-46,737
-67% -$2.03M ﹤0.01% 4428
2020
Q4 		$2.9M Buy
+69,695
New +$3.15M ﹤0.01% 2926

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Israel Englander's RLAY Position: Q2 2026 in Review

Israel Englander increased its Relay Therapeutics (RLAY) stake by 70% in Q2 2026, buying an estimated $3.54M and bringing the position to 591,675 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

Israel Englander first reported a position in RLAY in Q4 2020 and has held it in 21 quarters since. The position peaked at $19.8M in Q2 2023. 256 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Israel Englander held 591,675 shares of Relay Therapeutics worth $11.1M as of Q2 2026.
  • Israel Englander bought 243,942 Relay Therapeutics shares in Q2 2026, an estimated $3.54M.
  • Relay Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2185 holding.
  • Israel Englander first reported a position in Relay Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Israel Englander's Relay Therapeutics position peaked at $19.8M in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.